Safety and efficacy of sorafenib in patients with advanced thyroid carcinoma: a phase II study (NCT02084732)

Overview of attention for article published in Archives of Endocrinology and Metabolism, May 2021

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 9,234 followers.

RT @OfMetabolism: For the first time in Colombia, the efficacy of sorafenib was evaluated in patients with advanced and progressive thyroid…

RT @OfMetabolism: For the first time in Colombia, the efficacy of sorafenib was evaluated in patients with advanced and progressive thyroid…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.